Apr. 9, 2013 ? Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and leading to heart complications. Although many risk factors for atherosclerosis have been identified, the cause is not known and there is currently no way to reverse it once it sets in. In a new study published 9th April in the open access journal PLOS Biology, researchers have characterized the cells responsible for driving this calcium build-up in vessel walls.
The process of calcium accumulation in blood vessels resembles bone formation and involves maintaining a balance between bone-forming cells called osteoblasts and bone-destroying cells called osteoclasts. In the new study, Hyo-Soo Kim and colleagues characterize the origin of a population of vascular calcifying progenitor cells, and the potential of these cells to differentiate into different cell types.
"We show that vascular calcifying progenitor cells in the artery have the potential to become either osteoblasts or osteoclasts," said Dr Kim of Seoul National University. "And a certain chemical can push these cells towards becoming osteoclasts, which leads to the softening of the blood vessels."
The researchers sorted cells from the aortas of mice into two groups. Both groups originated from bone marrow and expressed a cell surface protein, called Sca-1, but only one group expressed another cell surface protein called PDGFR?. They found that the cells which only expressed Sca-1 could become either osteoblasts or osteoclasts, whereas the cells which expressed both Sca-1 and PDGFR? were committed to an osteoblastic lineage.
The team then treated the cells with a protein called PPAR?, which is known to promote the formation of osteoclasts and inhibit the formation of osteoblasts. When treated with PPAR?, only Sca-1 expressed cells preferentially differentiated into osteoclast-like cells. Furthermore, in vivo study demonstrated that, while bidirectional cells that were injected into mouse models of atherosclerosis increased the severity of calcium build-up in arteries, cells that were then treated with a drug activating PPAR? markedly decreased this effect and even reversed the calcification.
"These findings suggest that a subtype of calcifying progenitor cells offer a new therapeutic target for the prevention of calcification," said Dr Kim. "This opens up the possibility of new drug development to inhibit the hardening of the arteries, and thereby reduce the risk of heart disease."
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by Public Library of Science.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Hyun-Ju Cho, Hyun-Jai Cho, Ho-Jae Lee, Myung-Kang Song, Ji-Yun Seo, Yeon-Hee Bae, Ju-Young Kim, Hae-Young Lee, Whal Lee, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim. Vascular Calcifying Progenitor Cells Possess Bidirectional Differentiation Potentials. PLoS Biology, 2013; 11 (4): e1001534 DOI: 10.1371/journal.pbio.1001534
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
abc bradley cooper channing tatum Jennifer Aniston naomi watts Oscar Nominations 2013 Beasts of the Southern Wild
Docstoc, the online store for high-quality professional and business documents that made its debut at the TechCrunch40 conference back in 2007, today announced that it has partnered with Microsoft to sell its content directly to Microsoft Office users from within the Office applications. When Office users search for templates, they will now encounter Docstoc as a provider and can start the purchasing process from right inside Office. Currently, as Docstoc co-founder and CTO Alon Shwartz tells us, 10 Docstoc templates are available in Microsoft’s library (Partnership Agreement, Promissory Note, Resignation Letters, Power of Attorney, Buy-Sell Agreement, Independent Contractor Agreement, Employee Confidentiality Agreement, Offer to Purchase Real Estate, Contract for Sale of Goods and Non-disclosure Agreement). All of them retail for $24.95. In addition, Docstoc has also built an Office 365 and Office 2013 application that gives users direct access to all of the documents in the company’s library. As Docstoc notes, this partnership “aims to be a cost-effective option for entrepreneurs, startups and small businesses alike, who often lack the funds to buy the needed software.” Shwartz also told us that Microsoft chose to partner with his company because it believes “that the combination of our existing winning technology, high-quality content, deep understanding of the market, and successful experience with monetization of content is the best recipe for success.” Docstoc has more than 25 million registered users and has created over 12,000 templates and forms since its launch in 2007 (and there are millions of additional documents available on the service, too). Docstoc offers free and paid memberships, as well as the option to buy one-off documents on demand.